GE Healthcare launches new sensitive clinical PET/CT scanner in Middle East at Arab Health

The Discovery PET/CT 610 is available with Q.Suite, which is now available across the complete Discovery PET/CT portfolio.

"At GE Healthcare, we are committed to delivering what matters to clinicians and patients - low dose and quantitative accuracy, and that continues to form the foundation of our PET/CT products," said David Carr, General Manager of Molecular Imaging GE Healthcare for Middle East, Africa, Russia & CIS, Turkey & Central Asia. "We are excited to announce that the Discovery PET/CT 610 now joins Discovery PET/CT 710 in offering the ground-breaking Q.Suite technologies that could potentially contribute to personalized oncology care, enabling doctors to assess biological changes in a patient to assess the impact and course of treatment - allowing them to quickly and accurately modify treatment regimens."

Discovery PET/CT 610: The Most Sensitive Clinical PET Scanner

Sensitivity is one of the critical foundations of PET imaging, and this double-digit measurement of 10cps/kBq represents a critical milestone; it means the system is designed to collect the greatest number of counts in order to deliver fast and detailed scans at low dose. The Discovery PET/CT610 is optimized for today's widely-used Fluorine-based tracers and delivers what every highly-demanding clinical environment demands: exceptional performance with a keen focus on the best image quality possible.

GE Healthcare is also showcasing Q.Suite, which is now available on both the Discovery PET/CT 610 and Discovery PET/CT 710. Q.Suite is a collection of technologies designed to minimize and manage variability, and enable repeatable accuracy for standard uptake value (SUV) measurement from one exam to the next. That consistency in SUV measurements helps drive diagnostic confidence and enables clinicians to assess treatment response accurately. Q.Suite is designed to help improve consistency of quantitative measurements in every key area: daily quality control, scanner workflow, motion correction, reconstruction algorithms, and analysis, and reporting applications.

GE Healthcare PET/CT offerings deliver high-quality images with both low dose and quantitative accuracy. The advanced scanning technologies and software capabilities provide the precise data you need for everything from disease detection to treatment planning and monitoring. By combining the Optima CT 660 with the breakthrough motion management capabilities of the Discovery PET system, the new Discovery PET/CT platform brings clinically-relevant innovations designed to open doors to new and advanced procedure possibilities in non-invasive functional diagnostic imaging.

Q.Freeze - Full Thorax MotionFree PET/CT in Less Than 3 Minutes

Q.Freeze, a component of Q.Suite, addresses the clinical challenge of respiratory motion in PET/CT. It is the first ever imaging technique to combine the quantitative benefits of 4D PET/CT imaging into a single static image using 100% of the counts collected.

Dr. Guerra of San Gerardo Hospital - University of Milan, explained how they are seeing the impact of Q.Freeze within their clinical workflow, "With Q.Freeze, our aim is to provide respiratory motion correction PET/CT imaging whenever necessary within our daily clinical routine. Q.Freeze enables full thorax motion correction in less than 3 minutes in addition to our 10 minute conventional whole-body PET/CT protocol. Compared to conventional static PET imaging, Q.Freeze demonstrates a better image quality and higher diagnostic accuracy in detecting small lung and liver lesions."

Visit GE Healthcare's stand at Arab Health at Saeed Hall, Booth #S3B10 at the Dubai International Convention Center. With over 3,500 exhibitors, Arab Health is the world's longest running healthcare exhibition and congress and is now in its 38th year. About 85,000 visitors are expected to attend the event, from over 140 countries.

The Platinum Sponsor of Arab Health and a key partner of choice to healthcare providers across the Middle East, GE Healthcare will also present its diverse portfolio of products, services and customer solutions as part its commitment to strengthening the region's healthcare infrastructure.